← Leaderboards
Omer Kucuk
Wayne State University
$758,959
Attributed
$758,959
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$758,959 · 2
By mechanism
N01$758,959 · 2
Top collaborators
No co-investigators on record.
Most similar at Wayne State University
Same institution · by research overlap
- Boris Pasche$21,044,868
- Yong Q Chen$13,918,300
- Fazlul H. Sarkar$12,841,663
- Zora Djuric$7,927,294
- Ann G Schwartz$30,622,299
Others in their field
Top investigators on “Biomarker”
- David R. Weir · University Of Michigan At Ann Arbor$368,126,077
- Leonard Freedman · Leidos Biomedical Research, Inc.$248,231,562
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$217,859,034
- Ralph Parchment · Leidos Biomedical Research, Inc.$186,322,680
- Randall J Bateman · Washington University$182,177,358
- Paul S. Aisen · Cognition Therapeutics, Inc.$182,141,353
Research focus
BiomarkerBronchopulmonary DysplasiaCancer PreventionChemopreventionClinical ResearchDrug Screening /EvaluationEnzyme InhibitorsHuman SubjectHuman Therapy EvaluationLipoxygenaseLung NeoplasmsRespiratory Epithelium
Grant awards (3)
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022$0
N01 · FY2006 · CN · contact PI
PHASE II PROSTATE CLINICAL TRIAL OF MODULATION OF INTERMEDIATE ENDPOIN-261085083$0
N01 · FY2006 · CA · contact PI
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - W$758,959
N01 · FY2000 · CN